Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laubner, K.
Right arrow Articles by Seufert, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laubner, K.
Right arrow Articles by Seufert, J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:3410-3417, 2005
© 2005 by the American Diabetes Association, Inc.

Inhibition of Preproinsulin Gene Expression by Leptin Induction of Suppressor of Cytokine Signaling 3 in Pancreatic ß-Cells

Katharina Laubner1, Timothy J. Kieffer2, Ni T. Lam2, Xinjie Niu1, Franz Jakob1, and Jochen Seufert1

1 Division of Metabolism, Endocrinology and Molecular Medicine, Medizinische Klinik and Poliklinik II, University of Würzburg, Würzburg, Germany
2 Laboratory of Molecular and Cellular Medicine, the Departments of Cellular and Physiological Sciences and Surgery, University of British Columbia, Vancouver, British Columbia, Canada

Leptin inhibits insulin secretion and preproinsulin gene expression in pancreatic ß-cells, but signal transduction pathways and molecular mechanisms underlying this effect are poorly characterized. In this study, we analyzed leptin-mediated signal transduction and preproinsulin gene regulation at the molecular level in pancreatic ß-cells. Leptin stimulation led to janus kinase (JAK)2-dependent phosphorylation and nuclear translocation of the transcription factors signal transducer and activator of transcription (STAT)3 and STAT5b in INS-1 ß-cells. Leptin also induced mRNA expression of the JAK-STAT inhibitor suppressor of cytokine signaling (SOCS)3 in INS-1 ß-cells and human pancreatic islets in vitro and in pancreatic islets of ob/ob mice in vivo. Transcriptional activation of the rat SOCS3 promoter by leptin was observed with concomitant leptin-induced STAT3 and STAT5b DNA binding to specific promoter regions. Unexpectedly, SOCS3 inhibited both basal and STAT3/5b-dependent rat preproinsulin 1 gene promoter activity in INS-1 cells. These results suggest that SOCS3 represents a transcriptional inhibitor of preproinsulin gene expression, which is induced by leptin through JAK-STAT3/5b signaling in pancreatic ß-cells. In conclusion, although SOCS3 is believed to be a negative feedback regulator of JAK-STAT signaling, our findings suggest involvement of SOCS3 in a direct gene regulatory pathway downstream of leptin-activated JAK-STAT signaling in pancreatic ß-cells.


Address correspondence and reprint requests to Jochen Seufert, MD, Division of Metabolism, Endocrinology, and Molecular Medicine, Medizinische Klinik und Poliklinik II, University of Würzburg, Klinikstraße 6-8, 97070 Würzburg, Germany. E-mail: j.seufert{at}mail.uni-wuerzburg.de

Abbreviations: GFP, green fluorescent protein; JAK, janus kinase; {alpha}PY, anti-phosphotyrosine; SOCS, suppressor of cytokine signaling; STAT, signal transducer and activator of transcription; STATRE, STAT-responsive element


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
M. Jackerott, A. Moldrup, P. Thams, E. D. Galsgaard, J. Knudsen, Y. C. Lee, and J. H. Nielsen
STAT5 Activity in Pancreatic {beta}-Cells Influences the Severity of Diabetes in Animal Models of Type 1 and 2 Diabetes.
Diabetes, October 1, 2006; 55(10): 2705 - 2712.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.